Endometriosis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

Efficacy and Safety of BG2109 in Chinese Subjects With Endometriosis
Conditions:   Endometriosis;   Moderate to Severe Endometriosis-associated Pain Interventions:   Drug: BG2109 100mg;   Drug: BG2109 200mg;   Drug: ABT(E2 1 mg / NETA 0.5 mg);   Drug: BG2109 100mg Placebo;   Drug: BG2109 200mg Placebo;   Drug: ABT Placebo Sponsor:   Bio Genuine (Shanghai) Biotech Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2023 Category: Research Source Type: clinical trials